Merck reported FY2025 revenue of $65.0 billion and 2026 Q1 revenue of $16.3 billion. The thesis depends on Keytruda durability, pipeline conversion, R&D productivity, acquisition discipline and cash conversion.
The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.
